Please assess the completion status of the following clinical trial:

Trial Title: Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Informed consent~2. Established diagnosis of UC by the Paris classification and Revised Porto Criteria.~3. Age: 10 - 19 years (inclusive)~4. Mild to moderate active disease, 10 ≤ PUCAI ≤45~5. Extent E2-E4 by the Paris classification~6. Weight \>30 kg (ensures that patients who received 5ASA ≤2 grams are eligible)~7. Stable medication (IMM/ 5ASA) use or no change in medication use for the past 6 weeks. Patients who have received topical 5ASA therapy for \<10 days and are active may be included if topical therapy is stopped at enrolment.~8. Patients not receiving 5ASA or using 5ASA\<50mg/kg/day~Exclusion Criteria:~1. Any proven current infection such as positive stool culture, parasite or C. difficile.~2. Steroids (oral or intravenous) use in the past 3 months.~3. Patients who continue topical 5ASA or steroids after enrolment~4. Use of biologics in present or in past 6 months~5. Use of antibiotics for more than one week in the past 60 days~6. PUCAI \>45~7. Acute severe UC in the previous 12 months.~8. Current extra intestinal manifestation of UC.~9. Primary Sclerosing Cholangitis (PSC) or Liver disease~10. Pregnancy.~11. Vegans or patients unwilling or unable to consume eggs~12. Inflammatory Bowel Disease (IBD) unclassified~Exclusion criteria Comments:~1. Stool culture, parasite or C. difficile will only be measured if the patient has diarrhea.~2. Patients who have received treatment enemas for 3 weeks or less then 3 days and are active, can be included but must stop the enemas on the day of enrolment

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 19 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: EXPERIMENTAL): Control Diet 6 weeks of Oral 5ASA (standard recommended dosing 60-75 mg/kg/day; minimum 2.5, maximum 4 grams/day)+ Low residue diet and 6 more weeks of Oral 5ASA+ Free diet
- Group 2 (Type: EXPERIMENTAL): 6 weeks of Oral 5ASA (standard recommended dosing 60-75 mg/kg/day; minimum 2.5, maximum 4 grams/day)+ UC diet and 6 more weeks of Oral 5ASA+ UC diet stage 2

Based on this trial design, predict the completion outcome and termination type (if applicable).